These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 2611529)
1. The effects of UK-79,300, an orally-absorbed atriopeptidase inhibitor, in a conscious dog model of cardiac insufficiency. Alabaster CT; Machin I; Samuels GM; Sutton MR Br J Pharmacol; 1989 Dec; 98 Suppl():823P. PubMed ID: 2611529 [No Abstract] [Full Text] [Related]
2. The natriuretic and diuretic responses to the atriopeptidase inhibitor UK-69,578 in volume expanded rats. Barclay PL; Peters CJ; Bennett JA; Danilewicz JC; Samuels GM; Shepperson NB Br J Pharmacol; 1989 Dec; 98 Suppl():824P. PubMed ID: 2611530 [No Abstract] [Full Text] [Related]
3. The natriuretic and diuretic efficacy of atriopeptidase inhibitors following intravenous and oral administration. Shepperson NB; Samuels GM; Barclay PL; Ellis P Br J Pharmacol; 1989 Dec; 98 Suppl():822P. PubMed ID: 2611528 [No Abstract] [Full Text] [Related]
4. The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans. Jardine AG; Connell JM; Northridge D; Dilly SG; Cussans NJ; Davidson G; Doyle J; Leckie BL; Lever AF Am J Hypertens; 1990 Sep; 3(9):661-7. PubMed ID: 2145871 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats. Hirata Y; Suzuki E; Hayakawa H; Matsuoka H; Sugimoto T; Kangawa K; Matsuo H J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759 [TBL] [Abstract][Full Text] [Related]
7. Effects of atriopeptidase inhibitor UK 79300 on left ventricular hydraulic load in patients with congestive heart failure. Kromer EP; Elsner D; Kahles HW; Riegger GA Am J Hypertens; 1991 May; 4(5 Pt 1):460-3. PubMed ID: 1829902 [TBL] [Abstract][Full Text] [Related]
8. Dose-response relationship of a uricosuric diuretic. Emmerson BT; Thompson L; Mitchell K Adv Exp Med Biol; 1977; 76B():320-7. PubMed ID: 855758 [No Abstract] [Full Text] [Related]
9. Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects. Richards M; Espiner E; Frampton C; Ikram H; Yandle T; Sopwith M; Cussans N Hypertension; 1990 Sep; 16(3):269-76. PubMed ID: 2144260 [TBL] [Abstract][Full Text] [Related]
10. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Danilewicz JC; Barclay PL; Barnish IT; Brown D; Campbell SF; James K; Samuels GM; Terrett NK; Wythes MJ Biochem Biophys Res Commun; 1989 Oct; 164(1):58-65. PubMed ID: 2529858 [TBL] [Abstract][Full Text] [Related]
11. [Effect of the antiarrhythmic agent Aprindin (AC 1802) on the conductive of excitation and on the spontaneous automatics of the human heart]. Seipel L; Gleichmann U Z Kardiol; 1974 May; 63(3):426-34. PubMed ID: 4607897 [No Abstract] [Full Text] [Related]
12. The antipyretic effect of UP 517-03 in the rabbit. Hertz F; Chevrier MM; Dumeur G; Lwoff JM Agents Actions; 1979 Dec; 9(5-6):516-20. PubMed ID: 317572 [TBL] [Abstract][Full Text] [Related]
13. The effects of indanyloxyacetic acid (mk 196) on electrolyte excretion in the rat kidney. McKenzie R; Knight T; Weinman EJ Proc Soc Exp Biol Med; 1976 Nov; 153(2):202-4. PubMed ID: 995948 [No Abstract] [Full Text] [Related]